MicroSintesis Closes $16.4M Round

Charlottetown-based MicroSintesis, which has developed a revolutionary product to ensure gut health in animals, has sold a minority stake to John Risley’s Northern Private Capital for $16.4 million.
MicroSintesis is working in a new area of research called proteobiotic, which aims to rebalance the good and bad bacteria in an animal’s or person’s gut. The company has two products, which in total